In the US, methadone maintenance is restricted by federal and state regulations to large specialized clinics that serve fewer than 20% of the heroin-dependent population. In Europe, Canada, and Australia, primary health care providers already are utilized widely as methadone prescribers. In preparation for a limited study of office-based methadone treatment in New York City, 71 providers from 11 sites were surveyed about their willingness to prescribe methadone in their office-based practices. Of the 71, 85% had methadone-maintained patients who came to their practice for other care. One-third felt knowledgeable enough to prescribe methadone, and 66% said they would if given proper training and support (88% among AIDS care providers). Half expressed concern that they might be unable to meet the multiple needs of these patients. With additional training and ancillary support, the 47 providers willing to become methadone providers could serve, at 10-20 patients each, 470-940 patients, a population the size of 3-5 average methadone clinics.
INTRODUCTION
There is growing interest in office-based prescribing as a means of expanding and improving methadone maintenance treatment (MMT) in the US. Primary health care providers already are utilized widely as methadone prescribers throughout Europe, Australia, and Canada, 1' 2 and in some regions over 50% of methadone is prescribed in the offices of general practitioners and is dispensed in community pharmacies. [2] [3] [4] This approach has provided the chief means of expanding MMT availability Those providers who were unable to schedule an interview were asked to fill out the survey themselves and mail it, with telephone follow-up by the same interviewer; no differences were found in the two methods of responding.
SAMPLE
All respondents (physicians, physician assistants, and nurse practioners) worked in community-based primary care and HIV/AIDS clinics serving inner-city popu- in family medicine, internal medicine, and infectious disease and had been practicing an average of 10.2 years (see Table I ). Of a total of 99 clinicians employed at the 11 sites, 71 (72%) agreed to participate in the survey.
RESULTS

PRIOR EXPERIENCE WITH METHADONE PATIs
Most of these clinicians had extensive prior experience providing medical care for methadone patients: 85% currently had MMT patients in their practices, with a median of four patients in their care at the time of the study (see Table II ).
Providers in practices that treated HIV/AIDS were most experienced with methadone patients, as expected given the co-occurrence of HIV and heroin use in New York City. They reported a median of 40 MMT patients in their practices and had seen a median of 100 in their careers. Respondents said that they had also seen many more methadone patients--typically hospital inpatients--in the course of their clinical training. Five (5) practitioners volunteered that they had also worked in methadone treatment programs at some point in their careers, both as consultant medical providers and, in one case, as medical director of an MMT program.
ATTITUDES AND KNOWLEDGE REGARDING ADDICTION AND METHADONE MAINTENANCE TREATMENT
The majority (70%) of providers reported that they were "comfortable" managing the care of drug users in primary care (see Table III ), and 72% were convinced of methadone's effectiveness, supporting methadone "treatment on demand." 
WILLINGNESS TO PRESCRIBE METHADONE WITHIN THEIR PRACTICES
Of all practitioners surveyed, 66% said that, given proper training and support, they would prescribe methadone for their patients. However, there is concern that the "multiple needs" of methadone patients may be difficult to meet in these medical practice settings. Half (50%) of the providers shared this concern. In interviews, many practitioners saw the methadone patient population as having more complicated psychosocial needs and medical deficits than their average patient and called for additional supports.
Perhaps because they already saw the care of drug users as a substantial piece of their work, the HIV/AIDS providers in this sample were most enthusiastic about prescribing methadone: 88% of them were ready to prescribe. They felt somewhat more knowledgeable about MMT than most primary care providers--94% of the HIV/AIDS practitioners (versus 63% of the primary care practitioners) were comfortable working with drug users, and they were less concerned that they would be unable to meet the multiple needs of methadone patients.
CONCLUSIONS
For the practitioners we surveyed, the question of prescribing methadone was not laden with fear about bringing drug users into their practices--indeed most already had, and continue to have, substantial experience with methadone patients. Rather, methadone was seen as another useful tool for better managing the overall health of patients who are addicted. Over the past year as part of our NIDA research study, we have initiated methadone prescribing within primary care at our institutions, in which 15 primary care providers have assumed prescribing authority for 70 methadone patients currently enrolled in our MMT programs.
The principal finding of this study is that a significant proportion of these practitioners already were caring for the populations and communities most in 
